Negative Link Seen for Oxidative Balance Score With Chronic Kidney Disease
By Elana Gotkine HealthDay Reporter
FRIDAY, May 17, 2024 -- There is a negative association for oxidative balance score (OBS) with chronic kidney disease, according to a study published online April 23 in Frontiers in Nutrition.
Yuyu Cao, from the Seventh Clinical Medical College at the Guangzhou University of Chinese Medicine in Shenzhen, China, and colleagues examined the association between OBS, which reflects systemic stress status and includes 16 anti- and pro-oxidant dietary factors and four anti- and pro-oxidant lifestyle factors, and CKD among 8,134 study participants from the 2011 to 2018 National Health and Nutrition Examination Survey.
The researchers observed a negative association between OBS and CKD (odds ratio, 0.54). For each unit increase in OBS, the prevalence of CKD was reduced by 42 percent when dietary OBS was >20 and after adjustment for all confounders. In the female group, the negative associations of total OBS, dietary OBS, and lifestyle OBS with CKD were more significant. The trend of decreasing prevalence in the female group was more significant when the total OBS was about 20.
"Because our study had a cross-sectional design, we could not establish a causal relationship between OBS and CKD; therefore, more prospectively designed studies are needed to demonstrate the effectiveness of OBS," the authors write. "Nevertheless, our study findings, which revealed a negative association between OBS and CKD, have clinical relevance."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
Women Face Worse Chronic Kidney Disease Management in Primary Care
MONDAY, May 20, 2024 -- Women receive worse primary care-based chronic kidney disease (CKD) management than men, according to a research letter published online May 16 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.